Cargando…

LCK expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme

Glioblastoma multiforme (GBM) and primary central nervous system lymphoma (PCNSL) are both malignant cerebral tumors; however, their treatments are vastly different. Early and precise diagnosis is vital for subsequent adequate treatment to improve prognosis. Reliable biomarkers that can easily disti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Le, Xu, Lixia, Lu, Shan, Yan, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193164/ https://www.ncbi.nlm.nih.gov/pubmed/32237064 http://dx.doi.org/10.1002/2211-5463.12849

Ejemplares similares

(18)F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
por: Kong, Ziren, et al.
Publicado: (2019)

Near Misdiagnosis of Glioblastoma as Primary Central Nervous System Lymphoma
por: Bhatt, Vijaya Raj, et al.
Publicado: (2014)

Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma
por: Si, Pei-pei, et al.
Publicado: (2022)

Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016)

Radiomic features and multilayer perceptron network classifier: a robust MRI classification strategy for distinguishing glioblastoma from primary central nervous system lymphoma
por: Yun, Jihye, et al.
Publicado: (2019)

Gibbs process distinguishes survival and reveals contact-inhibition genes in Glioblastoma multiforme
por: Jahedi, Afrooz, et al.
Publicado: (2023)

Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
por: Malikova, H., et al.
Publicado: (2016)

Novel insights into the biomarkers and therapies for primary central nervous system lymphoma
por: Zhai, Yujia, et al.
Publicado: (2022)

Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors
por: Downs, Bradley M., et al.
Publicado: (2021)

COT-04 Circulating biomarker for glioblastoma and primary central nervous system lymphoma -Next Generation Sequencing of small noncoding RNA-
por: Onishi, Shumpei, et al.
Publicado: (2020)

Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016)

Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)

Primary central nervous system lymphoma
por: Löw, Sarah, et al.
Publicado: (2018)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Preoperative blood testing for glioblastoma, brain metastases, and primary central nervous system lymphoma differentiation
por: Wang, Song-Quan, et al.
Publicado: (2022)

Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks
por: McAvoy, Malia, et al.
Publicado: (2021)

New genetic prognostic biomarkers in primary central nervous system lymphoma (PCNSL)
por: Gomes Candido Reis, Diego, et al.
Publicado: (2021)

Genomic and Epigenomic Features of Glioblastoma Multiforme and its Biomarkers
por: Jadoon, Sarmad Sheraz, et al.
Publicado: (2022)

Biomarkers of Tumor Heterogeneity in Glioblastoma Multiforme Cohort of TCGA
por: Winkelmaier, Garrett, et al.
Publicado: (2023)

Lck bound to coreceptor is less active than free Lck
por: Wei, Qianru, et al.
Publicado: (2020)

Analysis of genomic alterations in primary central nervous system lymphoma
por: He, Xin, et al.
Publicado: (2023)

Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA
por: Yang, Qi, et al.
Publicado: (2018)

Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone—Searching for a practical approach
por: Neska-Matuszewska, Małgorzata, et al.
Publicado: (2018)

Primary intercavernous lymphoma of the central nervous system
por: Dultra, Arthur Henrique de Aquino, et al.
Publicado: (2015)

p56lck Signals for Regulating Thymocyte Development Can Be Distinguished by Their Dependency on Rho Function
por: Henning, Stefan W., et al.
Publicado: (1998)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
por: Qiao, Hao, et al.
Publicado: (2023)

Secondary gliosarcoma after the treatment of primary glioblastoma multiforme
por: Andaloussi-Saghir, Khalid, et al.
Publicado: (2011)

Morphometic analysis of TCGA glioblastoma multiforme
por: Chang, Hang, et al.
Publicado: (2011)

Comparison between Glioblastoma and Primary Central Nervous System Lymphoma Using MR Image-based Texture Analysis
por: Kunimatsu, Akira, et al.
Publicado: (2017)

Comparison of Radiomics-Based Machine-Learning Classifiers in Diagnosis of Glioblastoma From Primary Central Nervous System Lymphoma
por: Chen, Chaoyue, et al.
Publicado: (2020)

Deep learning for image classification between primary central nervous system lymphoma and glioblastoma in corpus callosal tumors
por: Jaruenpunyasak, Jermphiphut, et al.
Publicado: (2023)

Differentiation of glioblastoma and primary central nervous system lymphomas using multiparametric diffusion and perfusion magnetic resonance imaging
por: Hung, Nguyen Duy, et al.
Publicado: (2023)

Differentiating primary central nervous system lymphoma from glioblastoma by time-dependent diffusion using oscillating gradient
por: Kamimura, Kiyohisa, et al.
Publicado: (2023)

BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme
por: Xavier, Mary-Ann, et al.
Publicado: (2021)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

Are there primary intraocular lymphomas that do not develop into central nervous system lymphomas?
por: Matsuo, Toshihiko, et al.
Publicado: (2019)

Mutational analysis of primary central nervous system lymphoma
por: Bruno, Aurélie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fjeu46lui1m704b61o0g0eeou3